Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Reinholz M et al. S2k-Leitlinie Rosazea. AWMF-Registernummer 013-065; 2022
2. Schaller M et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol 2020;182:1269-76
3. Fowler J Jr et al. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5 % for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol 2013;12:650-6
4. Kircik LH et al. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0 % for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial. J Drugs Dermatol 2018;17:97-105
5. Wolf JE Jr, Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1 % gel compared with twice-daily azelaic acid 15 % gel in the treatment of rosacea. Cutis 2006;77:S3-11